Anna Wolska, MS, PhD, FAHA is a Staff Scientist at the Lipoprotein Metabolism Laboratory of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) in Bethesda, MD, USA where she leads several projects related to lipoprotein metabolism and cardiovascular diseases. She received her Master’s degree in 2009 at the University of Gdansk and PhD in 2014 at the Medical University of Gdansk (MUG) in Poland, where she also completed postgraduate studies in clinical laboratory medicine and became a certified Clinical Chemist. Since 2015 she has been working at the NHLBI in Dr. Alan T. Remaley’s laboratory. Dr. Wolska has over 15 years of experience in biomedical sciences and has broad training in basic science, translational medicine, molecular epidemiology, and drug development in the field of cardiovascular diseases. She also serves as a Communications Officer for the Lipoprotein and Vascular Diseases Division at the AACC and is a Fellow of the American Heart Association (FAHA).